Calmare Therapeutics Incorporated carries a market capitalization of 1,100.00, placing it among publicly traded companies globally.
| Market Cap | 1,100.00 |
| Enterprise Value | N/A |
Calmare Therapeutics Incorporated's stock has declined approximately -95% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Calmare Therapeutics Incorporated's most recent stock split took place on March 17, 1981 with a 2:3 split ratio.
| Last Split Date | 3/17/1981 |
| Split Ratio | 2:3 |